Understand the source comparison
Best Peptides for Bone Healing: Research Comparison
The evidence base for peptide-assisted bone healing is uneven across compounds. Some peptides have been studied in controlled human trials; most remain confined to animal models. The table below compares mechanism, research depth, and practical application. BP
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The evidence base for peptide-assisted bone healing is uneven across compounds. Some peptides have been studied in controlled human trials; most remain confined to animal models. The table below compares mechanism, research depth, and practical application.
- BPC-157
- VEGF upregulation, angiogenesis
- 38% faster fracture consolidation in rat femur models (J Orthop Res, 2019)
- Days 0–21 post-injury
- Strongest preclinical evidence for acute fractures; local injection preferred
- TB-500 (Thymosin Beta-4)
- Actin regulation, cell migration
- 60% increase in osteoprogenitor cell migration in bone defects (Ann NY Acad Sci, 2012)
- Weeks 0–4, systemic administration
- Best for complex trauma involving bone and soft tissue; requires higher doses
- GHK-Cu (Copper Peptide)
- Lysyl oxidase activation, osteoblast differentiation
- 42% increase in bone mineral density at 8 weeks in scaffold models (Biomaterials, 2015)
- Weeks 2–8, remodelling phase
- Supports late-stage mineralisation; synergistic with vitamin C
- Ipamorelin + CJC-1295
- Growth hormone secretagogue activity
- Indirect IGF-1 elevation associated with 15–20% increase in periosteal bone formation in aging models
- Continuous use, not injury-specific
- Systemic bone health rather than acute fracture recovery
- PTH (1-34) Fragment (Teriparatide)
- Parathyroid hormone receptor agonist
- FDA-approved for osteoporosis; shown to reduce vertebral fracture risk by 65% in postmenopausal women
- Prescription protocol only
- Gold standard for metabolic bone disease; not a research peptide